Fungal Infections in Solid Organ Transplant Patients

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Surgical Infections

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/109629603322419607PMID 14588161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Infectious complications after renal transplantation].

  2004cited by this paper
• A Randomized Double-blind Placebo-controlled Trial

  2004cited by this paper
• Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function

  2001cited by this paper
• Steroid‐free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial

  2001cited by this paper
• Fungal infections in the organ transplant recipient

  2001cited by this paper
• Liver transplantation using sirolimus and minimal corticosteroids (3‐day taper)

  2001cited by this paper
• Infections in recipients of kidney transplants.

  2001influential reference
• Infectious complications of lung transplantation

  2001influential reference
• Intravenous Itraconazole

  2001cited by this paper
• The current management of infectious diseases in the liver transplant recipient.

  2000influential reference
• Fluconazole in transplant recipients: options and limitations

  2000cited by this paper
• Decreased surgical risks of pancreas transplantation in the modern era.

  2000cited by this paper
• Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients.

  2000cited by this paper
• Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty‐first century

  1999cited by this paper
• Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.

  1999cited by this paper
• Invasive aspergillosis in transplant recipients.

  1999influential reference
• Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability

  1999cited by this paper
• What's new in pediatric organ transplantation.

  1999cited by this paper
• National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units.

  1999cited by this paper
• Cryptococcal meningitis in renal transplant patients associated with environmental exposure

  1999cited by this paper
• Epidemiology of fungal infections in solid organ transplant patients

  1999influential reference
• FUNGAL INFECTION IN THE ORGAN TRANSPLANT RECIPIENT

  1998influential reference
• Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

  1998cited by this paper
• Infections in solid organ transplant recipients

  1998influential reference
• Approaches to therapy for invasive mycoses--the role of amphotericin B.

  1998cited by this paper
• Ganciclovir/acyclovir and fluconazole prophylaxis after simultaneous kidney-pancreas transplantation.

  1998cited by this paper
• Importance of Candida species other than Candida albicans as opportunistic pathogens.

  1998cited by this paper
• Infectious complications following renal transplantation.

  1998influential reference
• Interactions between tacrolimus and antimicrobial agents.

  1997cited by this paper
• Infections in solid-organ transplant recipients

  1997cited by this paper
• Fungal Infections in Lung and Heart‐Lung Transplant Recipients: Report of 9 Cases and Review of the Literature

  1996cited by this paper
• Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.

  1996cited by this paper
• Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.

  1996influential reference
• Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients.

  1996cited by this paper
• Trends in the postmortem epidemiology of invasive fungal infections at a university hospital.

  1996cited by this paper
• Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

  1996cited by this paper
• Preliminary experience with intestinal transplantation in infants and children.

  1996cited by this paper
• Prdictive Value Of Inducible Endothelial Cell Adhesion Molecule Expression For Acte Rejection Of Human Cardiac Allografts

  1995cited by this paper
• Fungal infections in solid organ transplant recipients.

  1995influential reference
• Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study.

  1995cited by this paper
• Invasive aspergillosis after transplantation.

  1995cited by this paper
• Infectious complications in the first 100 days after renal transplantation.

  1995cited by this paper
• Clinical aspects of fungal infection in organ transplant recipients.

  1994cited by this paper
• Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

  1994cited by this paper
• High mortality in systemic fungal infections following renal transplantation in third-world countries.

  1993influential reference
• Infectious disease complications of renal transplantation.

  1993cited by this paper
• Fungal infections in solid-organ transplantation.

  1993cited by this paper
• Hereditary nephritis (Alport's syndrome)--clinical profile and inheritance in 28 kindreds.

  1993cited by this paper
• Infection in the transplanted and native lung after single lung transplantation.

  1993cited by this paper
• Infectious complications in heart-lung transplantation. Analysis of 200 episodes.

  1993cited by this paper
• [Infectious complications of heart-lung transplantation].

  1992cited by this paper
• TRIMETHOPRIM‐SULFAMETHOXAZOLE PROPHYLAXIS FOR PNEUMOCYSTIS CARINII INFECTIONS IN HEART‐LUNG AND LUNG TRANSPLANTATION—HOW EFFECTIVE AND FOR HOW LONG?

  1992cited by this paper
• Fungal infections in renal allograft recipients.

  1992cited by this paper
• Clinical spectrum of fungal infections after orthotopic liver transplantation.

  1991cited by this paper
• Cryptococcosis in a renal unit.

  1990cited by this paper
• Infectious complications in pulmonary allograft recipients.

  1990cited by this paper
• Cyclosporine and itraconazole interaction in heart and lung transplant recipients.

  1990cited by this paper
• Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations.

  1989cited by this paper
• [Pediatric organ transplantation].

  1989cited by this paper
• Infections after Liver Transplantation: AN ANALYSIS OF 101 CONSECUTIVE CASES

  1988cited by this paper
• Current status of liver transplantation.

  1987cited by this paper
• Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

  1987cited by this paper
• Infections in heart-lung transplant recipients.

  1986cited by this paper
• FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTS

  1985cited by this paper
• Fungal infections in liver transplant recipients

  1985cited by this paper
• Infectious complications in heart-lung transplant recipients.

  1985cited by this paper
• ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATION

  1983cited by this paper
• Infection following renal transplantation: a changing pattern.

  1982cited by this paper
• Mucormycosis in transplant patients.

  1980cited by this paper
• Fungal Infections in Renal Transplant Recipients

  1978cited by this paper
• [Fungal infections].

  1966cited by this paper

• Immunosuppressive and antiinfectious regimens in vascular composite allograft recipients—a systematic review

  2025cites this paper
• Residual neural networks in single instance-driven identification of fungal pathogens

  2023cites this paper
• Prevention and Management of Infections in Lung Transplant Recipients

  2023influential citation
• Management of Hospitalized Kidney Transplant Recipients for Hospitalists and Internists.

  2022cites this paper
• Catastrophic Brain Aspergillosis after Liver Transplantation

  2021cites this paper
• Biofilm Formation of Candida albicans Facilitates Fungal Infiltration and Persister Cell Formation in Vaginal Candidiasis

  2020cites this paper
• Characterization of non - albicans Candida species involved in human infections

  2019cites this paper
• Introduzione

  2019cites this paper
• Contemporary Kidney Transplantation

  2018cites this paper
• Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?

  2018cites this paper
• Infection in Kidney Transplantation

  2018cites this paper
• Candida Biofilms : Properties, Antifungal Resistance and Novel Therapeutic Options

  2017cites this paper
• Candida Parapsilosis: An Emerging Pathogen, Its Distribution and Antifungal Susceptibility to Fluconazole and Amphotericin B

  2017cites this paper
• Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis

  2016cites this paper
• Moonlight-like proteins of the cell wall protect sessile cells of Candida from oxidative stress.

  2016cites this paper
• Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms

  2016cites this paper
• Effect of Cytochrome P450 2C19 Genotyping and Therapeutic Drug Monitoring on Efficacy and Toxicity of Voriconazole Therapy

  2016influential citation
• Clinical isolates of Candida albicans, Candida tropicalis, and Candida krusei have different susceptibilities to Co(II) and Cu(II) complexes of 1,10-phenanthroline

  2015cites this paper
• Candida tropicalis as a Predominant Isolate from Clinical Specimens and its Antifungal Susceptibility Pattern in a Tertiary Care Hospital in Southern India.

  2015cites this paper
• Detection and Quantification of Fluconazole Within Candida glabrata Biofilms

  2015cites this paper
• Chapter 78 – Infections After Transplantation

  2015cites this paper
• Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

  2014cites this paper
• The effect of thyme and tea tree oils on morphology and metabolism of Candida albicans.

  2014cites this paper
• The impact of antifungals on toll-like receptors

  2014cites this paper
• Infectious Complications of Transplantation

  2014cites this paper
• Drug Interactions in Solid Organ Transplant Recipients

  2014cites this paper
• Effects of fluconazole on Candida glabrata biofilms and its relationship with ABC transporter gene expression

  2014cites this paper
• Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation

  2013cites this paper
• Invasive fungal infections in renal transplant recipients: about 11 cases.

  2013cites this paper
• Candida glabrata: a review of its features and resistance

  2013cites this paper
• Candida species: new insights into biofilm formation.

  2012cites this paper
• Association of topical amphotericin B lipid complex treatment to standard therapy for rhinomaxillary mucormycosis after liver transplantation: a case report.

  2012cites this paper
• Transplant-related Immunosuppression

  2012cites this paper
• Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.

  2012cites this paper
• Successful Treatment of Mucormycosis Infection after Liver Transplantation: Report of a Case and Review of the Literature

  2011cites this paper
• The increasing use of immunosuppressant medicines means that the number of invasive fungal infections is on the rise. Pharmacists should be able to identify the patients at risk of such infections

  2011cites this paper
• In Vitro Biofilm Activity of Non-Candida albicansCandida Species

  2010cites this paper
• Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients

  2010cites this paper
• Trends in the postmortem epidemiology of invasive fungal infections at a university hospital.

  2010cites this paper
• Caspofungin nach Transplantation solider Organe in Deutschland Beobachtungsstudie zur Behandlung invasiver Pilzinfektion

  2010cites this paper
• Caspofungin nach Transplantation solider Organe in Deutschland

  2010cites this paper
• Incidence and risk factors for pulmonary mycosis in kidney transplantation.

  2010cites this paper
• Analytic Reviews: Postoperative Infectious Complications of Abdominal Solid Organ Transplantation

  2009cites this paper
• THE ROLE OF PROGESTERONE IN THE REGULATION OF CILIARY ACTIVITY IN THE FALLOPIAN TUBE

  2009cites this paper
• Drug interactions in transplant patients: what everyone should know

  2009cites this paper
• Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.

  2009cites this paper
• PCR-Mediated Early Diagnosis of Fungal infections in Patients with Living-Donor Liver Transplants

  2009cites this paper
• Mucosal Candida infection and colonisation as well as associated risk factors in solid organ transplant recipients

  2009cites this paper
• Biofilm lifestyle of Candida: a mini review.

  2008cites this paper
• Fusarium solani in the Post-transplant Patient: An Unusual Fungus

  2008cites this paper
• MYCOTIC INFECTIONS OF THE LUNG

  2008cites this paper
• Invasive Pulmonary Aspergillosis after Liver Transplantation: Rapid and Complete Response to Combined and Sequential Antifungal Therapy

  2008cites this paper
• Radiological and clinical findings of pulmonary aspergillosis following solid organ transplant.

  2008cites this paper
• Posaconazole as Salvage Therapy in Patients With Invasive Fungal Infections After Solid Organ Transplant

  2008cites this paper
• Autopsy-proven causes of death in lungs of patients immunocompromised by secondary interstitial pneumonia.

  2007cites this paper
• Invasive fungal infections and antifungal therapies in solid organ transplant recipients

  2007cites this paper
• Efficacy and safety of caspofungin in solid organ transplant recipients.

  2007cites this paper
• Surgical Complications After Pancreatic Transplantation

  2006cites this paper
• Invasive fungal infections: a review of epidemiology and management options.

  2006influential citation
• Infectious Complications in Pancreas Transplant Recipients

  2006cites this paper
• Infection in cancer and transplantation

  2005cites this paper
• Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.

  2005cites this paper
• 64 – Infections After Liver Transplantation

  2005cites this paper
• An overview of fungal prophylaxis in lung transplantation

  2005cites this paper
• Mycobacterium xenopi infection after heart transplantation: an unreported pathogen.

  2004cites this paper